About Zhejiang Jiuzhou Pharmaceutical Company

The company was founded in 1998 to provide global pharmaceutical companies with one-stop drug R&D, production solutions and professional services from pre-clinical CMC, clinical phase I, II, and III, NDA to commercial listing, and set a successful example of transformation of traditional domestic generic API companies into innovative drug CDMO companies. The company is a technology-driven industry-leading CDMO enterprise dedicated to providing one-stop pharmaceutical customized R&D and production (CDMO) services for global pharmaceutical companies, biotechnology companies, scientific research institutions, etc. The main products are specialty raw materials and intermediates, fluorine reagents, high-performance enzymes, peptide chain modifications, peptide-conjugated drugs (PDC), small molecule conjugated drugs (SMDC), and nuclide conjugated drugs (RDCs). Corporate honors: It has successively won honors such as the top 100 enterprises in the national pharmaceutical industry, leading national API export enterprises, national high-tech enterprises, national technological innovation demonstration enterprises, the top 100 pharmaceutical industry enterprises in China, the “three” cultivation pilot enterprises in Zhejiang Province, and the “Jiuzhou” brand has won the “Zhejiang Export Famous Brand” and a national service-oriented manufacturing demonstration enterprise. The company won honors such as the top 100 enterprises in China's pharmaceutical industry, the most growing enterprise in China's pharmaceutical industry, the top 20 most competitive Chinese pharmaceutical listed companies, the 9th Zhejiang Provincial People's Government Quality Management Innovation Award, and the company won honors such as “2023 China's Top 20 Pharmaceutical CDMO Companies”, 2024 China's Top 20 Pharmaceutical CDMO Companies, and Zhejiang Biomedical Industry Leading Enterprise.